České Budějovice, 31st May – 2nd June 2023: 84. Kongres České́ společnosti Otorinolaryngologie a chirurgie hlavy a krku ČLS JEP  
The Czech Society of Otorhinolaryngology and Head and Neck Surgery establishes recommended practices in the field and ensures communication with other professional societies and governmental authorities.

In a poster presentation, AudioCure will share results from our Phase 1 Study conducted at Radboud University Medical Center (Radboudumc) in The Netherlands and Allgemeines Krankenhaus, Vienna:
AC102 – Phase I Results and Phase II Initiation for a New Drug Candidate for the Treatment of Sudden Sensorineural Hearing Loss. 16:35h, 31st May 2023

In this First-in-Human study, AC102 was well tolerated, allowing its application in patients in subsequent clinical trials. Consequently, AC102 is currently being evaluated in SSNHL patients in a Phase II clinical trial. In preclinical models, AC102 almost completely restores noise-induced hearing loss by preventing apoptosis of sensory cells and restoring synaptic integrity. More details of these findings will be provided by AudioCure CEO Reimar Schlingensiepen at a platform presentation:
AC102 in the Treatment of Functional Hearing Loss and Synaptopathy in a Guinea Pig Model of Noise-Induced Hearing Loss. 11:20h, 1st June 2023

AudioCure is very pleased to host a Study Meeting for our ongoing clinical trial AC102-201. In addition to an update on the trial, presentations will include the latest insights into the intratympanic injection technique (Nieratschker et al., 2022), and the use of steroids in sudden sensorineural hearing loss:
AC102-210 Study Meeting, Bezdrev / Hejtman Rooms, 14:00-15:30h, 1st June 2023

We welcome all healthcare professionals attending to join us: fostering collaborations and discussing key findings is vital to advance towards our common goal of finding treatments for those with hearing disorders.